三阴性乳腺癌微环境中旁分泌调控机制：从细胞通讯到肿瘤治疗
摘要
研究表明，肿瘤的旁分泌是形成 TNBC 肿瘤特殊微环境和转移、耐药的重要介质。多种细胞类型以及它们之间的交流网络
参与了这些过程，本文旨在综述 TNBC 中 TME 的旁分泌机制，并探讨其在肿瘤进展和治疗中的双重作用，并进一步提出
了针对 TNBC 的药物开发方向。
关键词
全文:
PDF参考
[1] R. Dent et al., 癌症三阴性：临床特征和复发模式的
癌症临床研究 . vol. 13, no. 15, pp. 4429–4434, Aug. 2007, doi:
10.1158/1078-0432.CCR-06-3045.
[2] O. Meurette and P. Mehlen, “Notch Signaling in
the Tumor Microenvironment,” Oct. 08, 2018, Cell Press. doi:
10.1016/j.ccell.2018.07.009.
[3] R. Huang et al., 靶 向 癌 症 相 关 脂 肪 细 胞 衍 生 的
CXCL8 抑制癌症三阴性进展并提高抗 PD-1 免疫疗法的疗效 .
Cell Death Dis, vol. 14, no. 10, Oct. 2023, doi: 10.1038/s41419-
023-06230-z.
[4] P. Yu et al., “The incorporation of acetylated
LAP-TGF-β1 proteins into exosomes promotes TNBC cell
dissemination in lung micro-metastasis,” Mol Cancer, vol. 23,
no. 1, Dec. 2024, doi: 10.1186/s12943-024-01995-z.
[5] A. Benedetti et al., ID4 依赖的 VEGFA 分泌增强了癌
症细胞的侵袭能力，并通过整合素 β3-VEGFR2 相互作用
激活 YAP/TAZ.Cell Death Dis, vol. 15, no. 2, p. 113, Feb. 2024,
doi: 10.1038/s41419-024-06491-2.
[6] S. Donzelli et al., “Paracrine Signaling from Breast
Cancer Cells Causes Activation of ID4 Expression in Tumor-
Associated Macrophages,” Cells, vol. 9, no. 2, Feb. 2020, doi:
10.3390/cells9020418.
[7] S. Ding et al., “Single-cell atlas reveals a distinct
immune profile fostered by T cell-B cell crosstalk in triple
negative breast cancer,” Cancer Commun, vol. 43, no. 6, pp.
661–684, Jun. 2023, doi: 10.1002/cac2.12429.
[8] A. E. Vilgelm and A. Richmond, “Chemokins modulate
immune surveillance in tumorignesis, metastatsis, and response
to immunotherapy,” 2019, Frontiers Media S.A. doi: 10.3389/
fimmu.2019.00333.
[9] X. Dong et al., “Exosomes and breast cancer drug
resistance,” Nov. 01, 2020, Springer Nature. doi: 10.1038/
s41419-020-03189-z.
[10] Q. Hao, Y. Wu, Y. Wu, P. Wang, and J. V. Vadgama,
“Tumor-Derived Exosomes in Tumor-Induced Immune
Suppression,” Feb. 01, 2022, MDPI. doi: 10.3390/ijms23031461.
[11] R. J. Lobb, L. G. Lima, and A. Möller, 外泌体：转移
和转移前小生境形成的关键介质 .Jul. 01, 2017, Elsevier Ltd.
doi: 10.1016/j.semcdb.2017.01.004.
[12] P. Qiu, Q. Guo, Q. Yao, J. Chen, and J. Lin, 外 显 子
相关基因风险模型在癌症三阴性患者肿瘤免疫微环境评估
和预后预测中的应用 . Front Immunol, vol. 12, Oct. 2021, doi:
10.3389/fimmu.2021.736030.
[13] D. Miroshnychenko et al., “Stroma-Mediated Breast
Cancer Cell Proliferation Indirectly Drives Chemoresistance by
Accelerating Tumor Recovery between Chemotherapy Cycles,”
Cancer Res, vol. 83, no. 22, pp. 3681–3692, 2023, doi:
10.1158/0008-5472.CAN-23-0398.
(3 摘要 Views, 9 PDF Downloads)
Refbacks
- 当前没有refback。